Skip to content

Nerve Conduction Block Using Transcutaneous Electrical Currents

Peripheral Nerve Conduction Block Using a High Frequency Alternating Stimulation: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03169049
Enrollment
10
Registered
2017-05-30
Start date
2017-07-31
Completion date
2017-09-30
Last updated
2017-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electric Stimulation, Nerve Block

Keywords

nerve conduction block, high frequency stimulation, handgrip

Brief summary

The purpose of this study is to determine whether the transcutaneous application of unmodulated high frequency alternating currents could produce a quickly conduction block of peripheral nerve.

Detailed description

In the last years several animal experimental studies have evidenced that high frequency unmodulated currents about 5 KHz can cause a peripheral nerve block. However electric currents with these high frequencies that are usually used for the treatment of pain in humans are interrupted or modulated (i.e. interferential currents). It has show that the diameter of the nerve it is related with the frequency to produce the conduction block. For this reason the investigators decided to applied 20KHz to observe the effects on maximal manual force and to compare versus sham stimulation. Only one study has applied 5KHz on experimental pain and they have demonstrated changes in somatosensory thresholds.

Interventions

high-Frequency electrical stimulation over superficial ulnar and median nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

DEVICEsham Stimulation

Sham transcutaneous electrical stimulation over superficial ulnar and median nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

Sponsors

Hospital Nacional de Parapléjicos de Toledo
CollaboratorOTHER
University of Castilla-La Mancha
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers

Exclusion criteria

* Neuromuscular disease. * Epilepsy. * Trauma, surgery or pain affecting the upper limb, shoulder girdle or cervical area. * Osteosynthesis material in the upper limb. * Diabetes. * Cancer. * Cardiovascular disease. * Pacemaker or other implanted electrical device. * Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics, ...) during the study and in the previous 7 days. * Presence of tattoos or other external agent introduced into the treatment or assessment area. * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Baseline Hand Muscle StrengthBaseline at 0 minThe hand muscle strength will be measured with a dynamometer and will be expressed in Newton
Hand muscle strength after treatment 20 minAfter treatment 20 minThe hand muscle strength will be measured with a dynamometer and will be expressed in Newton

Secondary

MeasureTime frameDescription
Change from baseline in Muscle strengthbaseline at 0 min, immediately after treatment at 20 minThe hand muscle strength will be measured with a dynamometer and will be expressed in Newton

Contacts

Primary ContactDiego Serrano-Muñoz, MsC
dserranomu@externas.sescam.jccm.es+34 925 24 77 00
Backup ContactJulio Gómez-Soriano, PhD
julio.soriano@uclm.es+34 925 26 88 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026